Original language | English |
---|---|
Pages (from-to) | 845-855 |
Number of pages | 11 |
Journal | Molecular Cancer Therapeutics |
Volume | 18 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2019 |
EphA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer
G. Martini, C. Cardone, P.P. Vitiello, V. Belli, S. Napolitano, T. Troiani, D. Ciardiello, C.M. Della Corte, F. Morgillo, N. Matrone, V. Sforza, G. Papaccio, V. Desiderio, M.C. Paul, V. Moreno-Viedma, N. Normanno, A.M. Rachiglio, V. Tirino, E. Maiello, T.P. Latiano
Research output: Contribution to journal › Article › peer-review